Stock Price
29.26
Daily Change
0.72 2.52%
Monthly
27.11%
Yearly
47.18%
Q1 Forecast
28.62

Celldex Therapeutics reported $-86.34M in EBITDA for its fiscal quarter ending in December of 2025.





Ebitda Change Date
AbbVie USD 3.52B 828M Sep/2025
Agenus USD -10.11M 19.02M Mar/2025
Amgen USD 5.14B 775M Dec/2025
Bristol-Myers Squibb USD 4.24B 967M Sep/2025
Celldex Therapeutics USD -86.34M 13.54M Dec/2025
Glaxosmithkline GBP 4.75B 1.52B Sep/2025
Nektar Therapeutics USD -31.81M 70K Sep/2023
Northwest Biotherapeutics USD -13.41M 232K Sep/2023
Pfizer USD 6.08B 351M Sep/2025
Rigel Pharmaceuticals USD -4.17M 798K Sep/2023
Roche Holding CHF 12.68B 2.36B Jun/2024